학술논문
CASC4/GOLM2 drives high grade serous carcinoma anoikis resistance through the recycling of EGFR
Document Type
Article
Author
Source
In: Cancer Gene Therapy . (Cancer Gene Therapy, February 2024, 31(2):300-310)
Subject
Language
English
ISSN
14765500
09291903
09291903